Ryan M. Bartolucci Sells 818 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 818 shares of the firm’s stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $81.87, for a total value of $66,969.66. Following the sale, the chief accounting officer now owns 46,182 shares in the company, valued at $3,780,920.34. This trade represents a 1.74 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Tempus AI Price Performance

NASDAQ:TEM opened at $68.09 on Friday. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The company’s 50-day moving average price is $50.29 and its 200-day moving average price is $51.65.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of TEM. Wells Fargo & Company MN grew its position in shares of Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after purchasing an additional 278 shares in the last quarter. First Horizon Advisors Inc. acquired a new position in Tempus AI during the third quarter worth $30,000. Geode Capital Management LLC boosted its stake in Tempus AI by 0.4% during the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after buying an additional 539 shares during the last quarter. Operose Advisors LLC purchased a new stake in Tempus AI in the 4th quarter valued at $25,000. Finally, Prestige Wealth Management Group LLC increased its stake in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after acquiring an additional 965 shares during the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

TEM has been the topic of a number of recent analyst reports. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and increased their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. TD Cowen reiterated a “buy” rating and set a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Bank of America boosted their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Piper Sandler restated a “neutral” rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Finally, Loop Capital dropped their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 14th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $58.55.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.